Compare MTB & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MTB | GEHC |
|---|---|---|
| Founded | 1856 | 1892 |
| Country | United States | United States |
| Employees | 22278 | N/A |
| Industry | Major Banks | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6B | 35.8B |
| IPO Year | N/A | 2022 |
| Metric | MTB | GEHC |
|---|---|---|
| Price | $196.96 | $70.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 12 |
| Target Price | ★ $225.03 | $90.83 |
| AVG Volume (30 Days) | 1.0M | ★ 2.7M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 3.00% | 0.19% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $9.92 | $7.06 |
| Revenue Next Year | $3.65 | $4.50 |
| P/E Ratio | ★ $13.63 | $15.86 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $150.75 | $57.65 |
| 52 Week High | $239.00 | $89.77 |
| Indicator | MTB | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 30.82 | 30.49 |
| Support Level | $191.45 | $69.64 |
| Resistance Level | $204.55 | $74.29 |
| Average True Range (ATR) | 5.46 | 2.04 |
| MACD | -2.12 | -0.73 |
| Stochastic Oscillator | 3.88 | 7.69 |
M&T Bank is a US regional bank with around $213 billion in assets as of Dec. 30, 2025. Headquartered in Buffalo, New York, the bank's footprint is mostly concentrated in New England and the US Mid-Atlantic. M&T Bank boasts a community banking approach, and boasts over 900 branches in 13 states and Washington, D.C. Apart from retail and commercial banking, M&T Bank also has wealth management operations through Wilmington Trust and a partnership with LPL Financial, and a corporate trust business.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).